Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Corcept Therapeutics, Inc. (NQ: CORT)
1.790 USD  -0.040 (-2.19%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Corcept Therapeutics, Inc.
 
< Previous 1 2 3 Next >
Corcept Therapeutics Announces First Quarter 2013 Financial Results
May 02, 2013
from Marketwired News Releases
Corcept Therapeutics to Announce First Quarter 2013 Financial Results and Host Conference Call
April 26, 2013
from Marketwired News Releases
New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012
March 22, 2013
Five Star Equities Provides Stock Research on Corcept Therapeutics and XenoPort Read More
from Marketwired News Releases
Corcept Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results
March 07, 2013
from Marketwired News Releases
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success in 2012
February 28, 2013
RDInvesting Provides Stocks Research on ADVENTRX Pharmaceuticals and Corcept Therapeutics Read More
from Marketwired News Releases
Corcept Therapeutics Announces Fourth Quarter and Full Year Revenue and Corporate Update
February 12, 2013
from Marketwired News Releases
Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash
January 23, 2013
Five Star Equities Provides Stock Research on Corcept Therapeutics and Savient Pharmaceuticals Read More
from Marketwired News Releases
Behind The Success - Research Report on Corcept Therapeutics Inc. and Dyax Corp.
January 23, 2013
Biotech firms Corcept and Dyax have each risen to the occasion with their innovative solutions for unmet medical needs, both having gained substantial momentum as of late Read More
from PR Newswire
Free Research Reports on CORT, CUR, EXM and SVU Issued by the Bedford Report
January 07, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Free Research Reports on AVGO, CMTL, CORT and LNG Issued by the Bedford Report
December 10, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
The Reason It Trades, What's Moving PPHM, CORT, CTIC and ACTC
December 10, 2012
from Marketwired News Releases
Perfect Trade Setups, How to Play PPHM, CORT, CTIC and ACTC
December 07, 2012
from Marketwired News Releases
The Real Story Behind UEPS, CORT, ACLS and ASYS
December 06, 2012
from Marketwired News Releases
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012
December 06, 2012
Five Star Equities Provides Stock Research on Corcept Therapeutics and NPS Pharmaceuticals Read More
from Marketwired News Releases
Free Research Reports on CENX, CORT, DVR and IQNT Issued by the Bedford Report
November 09, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Corcept Therapeutics Announces Third Quarter Results and Corporate Update
October 31, 2012
from Marketwired News Releases
Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors
October 15, 2012
from Marketwired News Releases
Corcept Therapeutics Announces $30 Million Synthetic, Capped Royalty Transaction; Terminates Committed Equity Financing Facility
August 07, 2012
from Marketwired News Releases
Corcept Therapeutics Announces Second Quarter Results and Corporate Update
August 07, 2012
from Marketwired News Releases
Corcept Therapeutics Announces Underwritten Public Offering of Common Stock
July 02, 2012
from Marketwired News Releases
Corcept Therapeutics Commences Public Offering of Common Stock
July 02, 2012
from Marketwired News Releases
Corcept Therapeutics Announces First Quarter Results and Corporate and Development Update
May 03, 2012
from Marketwired News Releases
Corcept Therapeutics Announces National Product Launch of Korlym(TM) for Patients With Endogenous Cushing's Syndrome
April 10, 2012
from Marketwired News Releases
UPDATE: Data Published in Premier Endocrinology Journal Shows Korlym(TM) Provides Significant Clinical Improvement in Patients With Endogenous Cushing's Syndrome
April 09, 2012
from Marketwired News Releases
Corcept Therapeutics Announces Exercise of Warrants and Private Placement of New Warrants
March 26, 2012
from Marketwired News Releases
Korlym(TM) (mifepristone), the First Approved Medication for Patients With Endogenous Cushing's Syndrome, to Be Available by April 11
March 22, 2012
from Marketwired News Releases
Corcept Therapeutics Announces Fourth Quarter Results and Corporate and Development Update
March 05, 2012
from Marketwired News Releases
Top Stock Alerts for Day Traders: Genworth Financial, RadioShack, Corcept Therapeutics, MGIC Investment, and DryShips
February 22, 2012
from PR Newswire
PWAV, THLD and CORT are the Stocks to Watch for February 22nd from OTCPicks.com
February 22, 2012
from EmailWire.Com Press Releases
THLD, CORT and COWI are the Daily Market Movers for February 21st from OTCPicks.com
February 21, 2012
from EmailWire.Com Press Releases
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here